1.Chen W, Tumanov S, Stanley C, Kong S, Nadel J, Vigder N, Newington D, Wang X, Dunn L, Stocker R. Destabilization of atherosclerotic plaque by bilirubin deficiency. Circulation Research. 2023;132:812 (IF: 23.2, JCR-Q1) 2.Xu X, Zhuang X, Yu H, Li P, Li X, Lin H, Teoh Jp, Chen Y, Yang Y, Cheng Y#, Chen W#, Fu X#. FSH induces EMT in ovarian cancer via ALKBH5-regulated Snail m6A demethylation. Theranostics 2024; 14:2151 (IF: 11.6, JCR Q1) 3.Nadel J, Wang X, Saha P, Bongers A, Tumanov S, Giannotti N, Chen W, Vigder N, Chowdhury MM, da Cruz GL, Velasco C, Prieto C, Jabbour A, Botnar RM, Stocker R, Phinikaridou A. Molecular magnetic resonance imaging of myeloperoxidase activity identifies culprit lesions and predicts future atherothrombosis. Eur Heart J Imaging Methods Pract. 2024;2:qyae004 (IF: 9.2, JCR Q1) 4.Chen W, Nadel, J, Tumanov S and Stocker R. Near infrared autofluorescence (NIRAF) in atherosclerotic plaque. Int. J. Mol. Sci. 2023, 24, 10727 (IF: 6.2, JCR Q1) 5.Chen W, Tumanov S, Kong S, Cheng D, Newington D, Michaëlsson E, Bongers A, Power C, Stocker R. Therapeutic inhibition of MPO stabilizes high risk vulnerable plaque. Redox Biology. 2022;58:102532. (IF: 10.8, JCR Q1) 6.Vigder N, Suarna C, Corcilius L, Nadel J, Chen W, Payne R, Tumanov S, Stocker R. An improved method for the detection of myeloperoxidase chlorinating activity in biological systems using the redox probe hydroethidine. Free Radic Biol Med. 2023;195:23 (IF: 8.1, JCR Q1) 7.Nadel J, Tumanov S, Chen W, Kong S, Giannotti N, Sivasubramanian V, Rashid I, Ugander M, Jabbour A, Stocker R. Intraplaque myeloperoxidase is a biomarker of unstable atheroma and adverse clinical outcomes in human atherosclerosis. JACC Adv. 2023, 3:100310 8.Kong W, Ma J, Lin Y, Chen W. Positive association of plasma trimethylamine-N-oxide and atherosclerosis in patient with acute coronary syndrome. Cardiovascular Therapeutics. 2022;2022:2484018. (IF:3.0, JCR Q2) 9.Chen W, Tumanov S, Fazakerley D, Cantley J, James D, Shaik T, Dunn L, Suarna C, Stocker R. Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance. Redox Biology. 2021;47:102152. (IF: 10.8, JCR Q1) 10.Lin X, Chen W, Wei F, Eradication of potential in-transit metastasis in breast-conserving surgery. JAMA Surgery. 2022;157:174. (IF: 16.7, JCR Q1) 11.Bortolussi G, Shi X, Bloemendaa, Banerjee B, Waart D, Baj G, Chen W, Elferink R, Beuers U, Paulusma C, Stocker R, Muro A, Bosma P. Genetic deletion of biliverdin reductase A prevents lethal neonatal hyperbilirubinemia in Ugt1–/– mice. Antioxidants (Basel). 2021; 10: 2029. (IF: 7.7, JCR Q1) 12.Dunn L*, Kong S*, Tumanov S, Chen W, Cantley J, Ayer A, Maghzal G, Midwinter R, Chan K, Ng M, Stocker R. Heme oxygenase-1 protects against ischemia-mediated injury via stabilization of hypoxia-inducible factor-1a, Arterioscler Thromb Vasc Biol. 2021;41:317. (IF: 10.5, JCR Q1) 13.Lin X*, Chen W*, Wei F, Xie X. TV-circRGPD6 Nanoparticle Suppresses Breast Cancer Stem Cell-Mediated Metastasis via the miR-26b/YAF2 Axis. Mol Ther. 2020; S1525: 30462. (IF: 12.9, JCR Q1) 14.Wei F*. Chen W*, Lin X. A clinical rule for the difficulty prediction on scalp intravenous access in infants (SIAI) from emergency room. Sci Rep. 2020; 10: 6624. (IF: 5.0, JCR Q2) 15.Wei F*, Chen W*, Lin X. HIFU ablation as a therapy for breast tumor: A meta-analysis of 23 prospective feasibility studies. Breast J. 2020; 26: 1478. (IF: 2.3, JCR Q3) 16.Wei F*, Chen W*, Lin X. Efficacy and safety of adjuvant endocrine therapy in premenopausal patients with early-stage hormone receptor-positive breast cancer: A meta-analysis of randomized controlled trials. Breast J. 2019; 25: 1297. (IF: 2.3, JCR Q3) 17.Chen W and Stocker R. Absence of bilirubin increases oxidative stress in vivo. Atlas of Science. 2018; 18.Chen W, Maghzal G, Ayer A, Suarna C, Dunn L, Stocker R. Absence of the Bvra gene is associated with increased endogenous oxidative stress. Free Radic Biol Med. 2018; 115: 156. (IF: 8.1, JCR Q1) 19.Li X*, Chen W*, Li P, Wei J, Cheng Y, Liu P, Yan Q, Xu X, Cui Y, Gu Z, Simoncini T, Fu X. Follicular stimulating hormone accelerates atherogenesis by increasing endothelial VCAM-1 expression. Theranostics. 2017; 7: 4671. (IF: 11.6, JCR Q1) 20.Lin X*, Chen W*, Wei F, Zhou B, Hung M, Xie X. Nanoparticle delivery of miR-34a eradicates long-term-cultured breast cancer stem cells via targeting C22ORF28 Directly. Theranostics. 2017; 7: 4805. (IF: 11.6, JCR Q1) 21.Lin X*, Chen W*, Wei F, Zhou BP, Hung MC, Xie X. POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells. Int J Cancer. 2017; 140: 2517. (IF: 7.4, JCR Q1) 22.Li P, Wei J, Li X, Cheng Y, Chen W, Cui Y, Simoncini T, Gu Z, Yang J, Fu X. 17β-estradiol enhances vascular endothelial Ets-1/miR-126-3p expression: the possible mechanism for attenuation of atherosclerosis. J Clin Endocrinol Metab. 2017; 102: 594. (IF: 6.1, JCR Q2) 23.Chen W, Cui Y, Li P, Simoncini T, Zhang Y, Fu X. 2-methoxyestradiol induces vasodilation by stimulating NO release via PPARγ/PI3K/Akt pathway. PLoS One. 2015; 10: e0118902. (IF: 3.8, JCR Q2) 24.Lin X*, Chen W*, Wei F, Ying M, Wei W, Xie X. Night-shift work increases morbidity of breast cancer and all-cause mortality: a meta-analysis of 16 prospective cohort studies. Sleep Med. 2015; 16: 1381. (IF: 4.8, JCR Q2) 25.Lin X, Li J, Chen W, Wei F, Ying M, Wei W, Xie X. Diabetes and risk of anastomotic leakage after gastrointestinal surgery. J Surg Res. 2015; 196: 294. (IF: 2.4, JCR Q2) 26.Chen W, Cheng Y, Li P, Fu X. The mechanistic exploration on the role of GPR30 in estrogen-promoted breast cancer cell migration and invasion. Anat Res. 2015; 37: 93. 27.Fu X, Huang X, Li P, Chen W, Xia M. 7-Ketocholesterol inhibits isocitrate dehydrogenase 2 expression and impairs endothelial function via microRNA-144. Free Radic Biol Med. 2014; 71: 1. (IF: 8.1, JCR Q1) 28.Li P, Chen W, Cheng Y, Fu X. 17β-estradiol inhibits the expression of VCAM-1 in endothelial cell via microRNA-126. Anat Res. 2014; 36: 128. *Co-first author, impact factor refers to 2023 |
